Position in HLN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$76,664
+$919 QoQ
Shares Held
8,217
+8.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#105
of 221 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Wilmington Savings Fund Society, FSB holds $1,602,795 across 14 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
20,783 | $1,088,925 | |
| 2 | ADCT |
ADC Therapeutics SA
|
100,000 | $107,000 | |
| 3 | VTRS |
Viatris Inc
|
6,562 | $104,203 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,413 | $81,752 | |
| 5 | HLN |
Haleon plc
This page
|
8,217 | $76,664 | |
| 6 | ZTS |
Zoetis Inc.
|
857 | $61,583 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
329 | $36,498 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
500 | $23,255 |
All Filings in HLN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,664 | 8,217 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $75,745 | 7,567 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $75,511 | 7,469 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $66,996 | 7,469 | Shares | Defined | 2025-11-20 | |
| 2025-06-30 | $228,367 | 22,022 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $254,810 | 24,763 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $218,064 | 22,858 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $203,251 | 19,211 | Shares | Defined | 2024-11-25 | |
| No filing history on record for this holder in this stock. | ||||||